Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2008. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 47413301000001116 | Betaloc (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| 47413401000001112 | Betaloc | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Betaloc | Is a | Trade family | true | Inferred relationship | Existential restriction modifier | ||
| Betaloc | Has trade family group | Betaloc | false | Inferred relationship | Existential restriction modifier | ||
| Betaloc | Has trade family group | Betaloc | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Betaloc 50mg tablets (AstraZeneca) | Is a | True | Betaloc | Inferred relationship | Existential restriction modifier | |
| Betaloc 100mg tablets (AstraZeneca) | Is a | True | Betaloc | Inferred relationship | Existential restriction modifier | |
| Betaloc I.V. 5mg/5ml solution for injection ampoules (Recordati Pharmaceuticals Ltd) | Is a | True | Betaloc | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR